Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYSCHEM (I). vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SYSCHEM (I).   TEVA PHARMA
EQUITY SHARE DATA
    SYSCHEM (I).
Mar-23
TEVA PHARMA
Dec-13
SYSCHEM (I)./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs653,479-   
Low Rs113,022-   
Sales per share (Unadj.) Rs30.31,996.4-  
Earnings per share (Unadj.) Rs1.4124.7-  
Cash flow per share (Unadj.) Rs2.3286.1-  
Dividends per share (Unadj.) Rs0109.18-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs7.02,217.6-  
Shares outstanding (eoy) m31.89848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.6 77.3%   
Avg P/E ratio x27.026.1 103.5%  
P/CF ratio (eoy) x16.911.4 148.4%  
Price / Book Value ratio x5.51.5 372.2%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m1,2172,756,220 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m440-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m9671,692,969 0.1%  
Other income Rs m20-   
Total revenues Rs m9701,692,969 0.1%   
Gross profit Rs m86463,620 0.0%  
Depreciation Rs m27136,844 0.0%   
Interest Rs m033,253 0.0%   
Profit before tax Rs m62293,523 0.0%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m16-3,584 -0.5%   
Profit after tax Rs m45105,758 0.0%  
Gross profit margin %8.927.4 32.6%  
Effective tax rate %26.6-1.2 -2,180.6%   
Net profit margin %4.76.2 74.7%  
BALANCE SHEET DATA
Current assets Rs m5861,143,425 0.1%   
Current liabilities Rs m430997,163 0.0%   
Net working cap to sales %16.18.6 186.6%  
Current ratio x1.41.1 118.8%  
Inventory Days Days491 4.4%  
Debtors Days Days1,58296 1,649.9%  
Net fixed assets Rs m319552,961 0.1%   
Share capital Rs m3194,167 7.7%   
"Free" reserves Rs m-960-   
Net worth Rs m2231,880,567 0.0%   
Long term debt Rs m16865,653 0.0%   
Total assets Rs m9043,868,976 0.0%  
Interest coverage x147.59.8 1,500.5%   
Debt to equity ratio x0.10.5 15.6%  
Sales to assets ratio x1.10.4 244.5%   
Return on assets %5.03.6 140.2%  
Return on equity %20.25.6 359.8%  
Return on capital %25.94.9 525.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-85269,772 -0.0%  
From Investments Rs m91-95,591 -0.1%  
From Financial Activity Rs mNA-323,609 0.0%  
Net Cashflow Rs m5-149,429 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SYSCHEM (I). With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SYSCHEM (I). With: GLAND PHARMA  BERYL DRUGS  ZENITH HEALTH  DISHMAN PHARMA  KABRA DRUGS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.